The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial
Open accessAbstract
CONTEXT: Experimental and epidemiological data suggest that vitamin E supplementation may prevent cancer and cardiovascular events. Clinical trials have generally failed to confirm benefits, possibly due to their relatively short duration. OBJECTIVE: To evaluate whether long-term supplementation with vitamin E decreases the risk of cancer, cancer death, and major cardiovascular events. DESIGN, SETTING, AND PATIENTS: A randomized, double-blind, placebo-controlled international trial (the initial Heart Outcomes Prevention Evaluation [HOPE] trial conducted between December 21, 1993, and April 15, 1999) of patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE-The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003. Of the initial 267 HOPE centers that had enrolled 9541 patients, 174 centers participated in the HOPE-TOO trial. Of 7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up. Median duration of follow-up was 7.0 years. INTERVENTION: Daily dose of natural source vitamin E (400 IU) or matching placebo. MAIN OUTCOME MEASURES: Primary outcomes included cancer incidence, cancer deaths, and major cardiovascular events (myocardial infarction, stroke, and cardiovascular death). Secondary outcomes included heart failure, unstable angina, and revascularizations. RESULTS: Among all HOPE patients, there were no significant differences in the primary analysis: for cancer incidence, there were 552 patients (11.6%) in the vitamin E group vs 586 (12.3%) in the placebo group (relative risk [RR], 0.94; 95% confidence interval [CI], 0.84-1.06; P = .30); for cancer deaths, 156 (3.3%) vs 178 (3.7%), respectively (RR, 0.88; 95% CI, 0.71-1.09; P = .24); and for major cardiovascular events, 1022 (21.5%) vs 985 (20.6%), respectively (RR, 1.04; 95% CI, 0.96-1.14; P = .34). Patients in the vitamin E group had a higher risk of heart failure (RR, 1.13; 95% CI, 1.01-1.26; P = .03) and hospitalization for heart failure (RR, 1.21; 95% CI, 1.00-1.47; P = .045). Similarly, among patients enrolled at the centers participating in the HOPE-TOO trial, there were no differences in cancer incidence, cancer deaths, and major cardiovascular events, but higher rates of heart failure and hospitalizations for heart failure. CONCLUSION: In patients with vascular disease or diabetes mellitus, long-term vitamin E supplementation does not prevent cancer or major cardiovascular events and may increase the risk for heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, despite this, vitamin E did not improve cardiovascular outcomes in a large multicenter trial and actually increased congestive heart failure (201).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [201]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Bjelaković, G., Nikolova, D., Simonetti, R. G., & Gluud, C. N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17138-9 · Cited by 619
Vitamin E in Humans: Demand and Delivery
Traber, M. G., & Sies, H. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001541 · Cited by 502
Jha, P., Flather, M., Lonn, E., Farkouh, M., & Yusuf, S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-11-199512010-00009 · Cited by 399
SERUM VITAMIN E AND RISK OF CANCER AMONG FINNISH MEN DURING A 10-YEAR FOLLOW-UP
Knekt, P., Aromaa, A., Maatela, J., Aaran, R., Nikkari, T., Hakama, M., Hakulinen, T. R., Peto, R., Saxén, E., & Teppo, L. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114788 · Cited by 233
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
Steinberg, D. H. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92657-7 · Cited by 178
Huang, H.-Y. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf210 · Cited by 173
Research works printed but not linked: 18
- Verlangieri AJ, Bush MJ. Effects of d-␣-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr. 1992;11:131-138.
- Meydani M. Vitamin E. Lancet. 1995;345:170-175.
- Skyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: a randomized, pla- cebo-controlled study. J Am Coll Cardiol. 2000;36:94- 100.
- Sigounas G, Anagnostou A, Steiner M. dl-alpha- Tocopherol induces apoptosis in erythroleukemia, pros- tate, and breast cancer cells. Nutr Cancer. 1997;28:30- 35.
- Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer [review]. Cancer Causes Control. 1996;7:157- 177.
- Longnecker MP, Martin-Moreno JM, Knekt P, et al. Serum alpha-tocopherol concentration in relation to sub- sequent colo-rectal cancer: pooled data from five cohorts. J Natl Cancer Inst. 1992;84:430-445.
- Ocke MC, Bueno-de-Mesquita HB, Feskens EJ, van Staveren WA, Kromhout D. Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer: the Zutphen Study. Am J Epidemiol. 1997;145:358-365.
- Klein EA, Thompson IM, Lippman SM, et al. SELECT: the next prostate cancer prevention trial: Selenium and Vitamin E Cancer Prevention Trial. J Urol. 2001;166:1311- 1315.
- Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with ␣-tocopherol and -carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440-446.
- Li J-Y, Taylor PR, Li B, et al. Nutrition intervention trials in China: multiple incidence and disease-specific mor- tality among adults with esophageal dysplasia. J Natl Can- cer Inst. 1993;85:1492-1498.
- The Alpha-Tocopherol, Beta Carotene Cancer Pre- vention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other can- cers in male smokers. N Engl J Med. 1994;330: 1029-1035.
- Steinberg D, Witzum JL. Is the oxidative modifi- cation hypothesis relevant to human atherosclerosis: do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107-2111.
- The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardio- vascular events in high-risk patients. N Engl J Med. 2000;342:154-160.
- Lonn E, Shaikholeslami R, Yi Q, et al. Effects of ramipril on left ventricular mass and function in car- diovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a sub- study of the HOPE trial. J Am Coll Cardiol. 2004;43: 2200-2206.
- GISSI-Prevenzione Investigators (Gruppo Itali- ano per lo Studio della Sopravvivenza nell'Infracto Miocardico). Dietary supplementation with n-e poly- unsaturated fatty acids and vitamin E after myocar- dial infarction: results of the GISSI-Prevenzione Trial. Lancet. 1999;354:447-455.
- Age-Related Eye Disease Study Group. A ran- domized, placebo-controlled, clinical trial of high-dose supplementation with vitamin C and E and beta-carotene for age-related cataract and vi- sion loss: AREDS Report No. 9. Arch Ophthalmol. 2001; 119:1439-1452.
- Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001;342:154-160.
- Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoproteins: when and how this antioxidant becomes a pro-oxidant. Biochem J. 1992; 288:341-344.
Cited by
Sorted by citations
Items 701–800 of 999
Levine, M. N., Ebenuwa, I., & Violet, P.-C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-805378-2.00018-8 · Cited by 17
Research in Nutrition and Dietetics—What Can the Academy Do for You?
Hand, R. K. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.11.007 · Cited by 15
Ganini, D., & Mason, R. P. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.031 · Cited by 15
“Based on our results, the absence of any beneficial effect of oral supplementation with vitamin E in humans for the prevention of cardiovascular disease [68,69] is not surprising because, in vivo, the oxidation of LDL is mainly mediated by lipoxygenases and, as shown here with the soybean enzyme, α-tocopherol is unabl…”
Sallam, N. A., Fisher, A., Golbidi, S., & Laher, I. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0614-1 · Cited by 17
Common Dietary Supplements for Cognitive Health
Gestuvo, M., & Hung, W. (2012) · Aging Health · doi:10.2217/ahe.11.92 · Cited by 15
Regulation of Cardiac PKA Signaling by cAMP and Oxidants
Cuello, F., Herberg, F. W., Σταθοπούλου, Κ., Henning, P., & Diering, S. (2021) · Antioxidants · doi:10.3390/antiox10050663 · Cited by 16
Free radicals and antioxidants: Myths, facts and mysteries
Abid, A., Shaiq, A. G., Ahanger, R. A., Hilal, A., Tauseef, A. B., & Imtiyaz, A. W. (2013) · African Journal of Pure and Applied Chemistry · doi:10.5897/ajpac12.074 · Cited by 14
“In fact, when the HOPE trial was extended for another four years, researchers found that study volunteers who took vitamin E had a higher risk of heart failure (Lonn et al., 2005).”
BackgroundHantikainen, E. M., Löf, M., Grotta, A., Lagerros, Y. T., Serafini, M., Bellocco, R., & Weiderpass, E. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0361-4 · Cited by 13
Huang, J., Hodis, H. N., Weinstein, S. J., Mack, W. J., Sampson, J. N., Mondul, A. M., & Albanes, D. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0187 · Cited by 14
Mitohormesis; Potential implications in neurodegenerative diseases
Gohel, D., & Singh, R. K. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.011 · Cited by 14
Reed, B. N., Rodgers, J. E., & Sueta, C. A. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.07.005 · Cited by 18
A 76-Year-Old Man With Macular Degeneration
Arroyo, J. G. (2006) · JAMA · doi:10.1001/jama.295.20.2394 · Cited by 14
“03) in the Heart Outcomes Prevention Evaluation (HOPE) trial.(64) A large meta-analysis of 135 967 participants in 19 clinical trials of vitamin E found that the pooled all-cause mortality risk difference in high-dose ( 400 IU) vitamin E trials was 39 per 10 000 persons (95% CI, 3-74 per 10 000 persons; P=.”
BackgroundPeptide screen identifies a new NADPH oxidase inhibitor: impact on cell migration and invasion
Mousslim, M., Pagano, A., Andreotti, N., Garrouste, F. L., Thuault, S., Peyrot, V., Parat, F., Luis, J., Culcasi, M., Laurent, S., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.011 · Cited by 14
Could Adjunctive Pharmacology Mitigate Cardiovascular Consequences of Obstructive Sleep Apnea?
Ayas, N., Foster, G. E., Shah, N. A., Floras, J. S., & Laher, I. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201811-2097pp · Cited by 14
Changes in Vitamin E Prescribing for Alzheimer Patients
Dysken, M. W., Kirk, L. N., & Kuskowski, M. A. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a31fcf · Cited by 14
Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer.
Buring, J. E. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.9.863 · Cited by 14
Statin Treatment as a Confounding Factor in Human Trials with Vitamin E
Violi, F., & Cangemi, R. (2008) · Journal of Nutrition · doi:10.1093/jn/138.6.1179 · Cited by 14
Vitamin E Induces Liver Iron Depletion and Alters Iron Regulation in Mice
Baratz, E., Protchenko, O. V., Jadhav, S., Zhang, D., Violet, P.-C., Grounds, S., Shakoury‐Elizeh, M., Levine, M., & Philpott, C. C. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.04.018 · Cited by 13
Dietary antioxidants and vascular calcification: From pharmacological mechanisms to challenges
Lian, Y., Li, Y., Liu, A., Ghosh, S., Shi, Y., & Huang, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115693 · Cited by 13
Antioxidants as a preventive therapeutic option for age related neurodegenerative diseases
(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.592 · Cited by 13
Agarwal, M., Mehta, P. K., Dwyer, J. H., Dwyer, K. M., Shircore, A. M., Nordstrom, C. K., Sun, P., Paul-Labrador, M. J., Yang, Y., & Merz, C. N. B. (2012) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401206010113 · Cited by 13
“Of note, vitamin supplementation (C, D, E) in general has not been shown to consistently reduce the risk of diseases, such as cancer, where theoretically the role of anti-oxidants vitamins should be beneficial [43-46].”
Lin, S. C., Ang, B., Hernandez, C., Bettencourt, R., Jain, R., Salotti, J., Richards, L., Kono, Y., Bhatt, A., Aryafar, H., et al. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15621232 · Cited by 13
Mass Spectrometry in Advancement of Redox Precision Medicine
Chen, X., Lee, J., Wu, H., Tsang, A. W., & Furdui, C. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-15950-4_19 · Cited by 12
Simsek, B., Selte, A., Egeli, B. H., & Çakatay, U. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.02.014 · Cited by 13
Can vitamin E prevent cardiovascular events and cancer?
Widder, J. D., & Harrison, D. G. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0291 · Cited by 13
Celık, T., Yüksel, C., & Iyısoy, A. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.02.005 · Cited by 13
Khallouki, F., Owen, R. W., Akdad, M., Bouhali, B. E., Silvente‐Poirot, S., & Poirot, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811907-5.00001-4 · Cited by 13
α-Tocopherol induces proatherogenic changes to HDL2 & HDL3: An in vitro and ex vivo investigation
Wade, L., Nadeem, N., Young, I. S., Woodside, J. V., McGinty, A., McMaster, C., & McEneny, J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.032 · Cited by 13
Overview of Nutritional Epidemiology
Villaseñor, A., Cadmus‐Bertram, L., & Patterson, R. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00007-2 · Cited by 13
Urological Oncology: Prostate Cancer
Walsh, P. C. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.07.046 · Cited by 13
Low-Dose Aspirin and Vitamin E
Jacobs, E. J., & Thun, M. J. (2005) · JAMA · doi:10.1001/jama.294.1.105 · Cited by 13
Sangweni, N. F., Mosa, R. A., Dludla, P. V., Kappo, A. P., Opoku, A. R., Muller, C. J. F., & Johnson, R. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153546 · Cited by 12
Jung, W. K., Park, S., Yu, H. Y., Kim, Y. H., & Kim, J. (2022) · Molecules · doi:10.3390/molecules27248970 · Cited by 12
“Furthermore, vitamin E increases the risk of prostate cancer, vascular disease, and diabetic heart failure [43,44].”
BackgroundChaudhari, M., Zelko, I. N., Lorkiewicz, P. K., Hoetker, D., Nong, Y., Doelling, B., Brittian, K. R., Bhatnagar, A., Srivastava, S., & Baba, S. P. (2024) · Skeletal Muscle · doi:10.1186/s13395-024-00354-2 · Cited by 12
Cairns, J. A., Yusuf, S., Cook, R. J., Cox, J. L., Dagenais, G. R., Devereaux, P. J., McAlister, F. A., & McCready, T. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70408-6 · Cited by 12
Preparation and Certification of Standard Reference Material 3278 Tocopherols in Edible Oils
Rimmer, C. A., Putzbach, K., Sharpless, K. E., Sander, L. C., & Yen, J. H. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2051619 · Cited by 12
Reincarnated medicines: using out-dated drugs for novel indications
Ferrari, R., & Lüscher, T. F. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw051 · Cited by 12
Chasing great paths of Helmut Sies “Oxidative Stress”
Majima, H. J., Indo, H. P., Nakanishi, I., Suenaga, S., Matsumoto, K., Matsui, H., Minamiyama, Y., Ichikawa, H., Yen, H., Hawkins, C. L., et al. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.10.023 · Cited by 12
Antioxidant Supplements: Friend or Foe?
Sen, S., & Chakraborty, R. (2014) · Springer eBooks · doi:10.1007/978-81-322-2035-0_19 · Cited by 11
Relationship between calculated total antioxidant status and atherosclerotic coronary artery disease
Anvari, M. S., Babaki, M. M., Boroumand, M. A., Eslami, B., Jalali, A., & Goodarzynejad, H. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6482 · Cited by 12
“Results from clinical trials using antioxidant supplementation for improving cardiovascular outcomes in humans have, however, not been as promising as expected (21, 22), and whether antioxidant interventions actually succeeded in decreasing ROS levels and oxidative stress was never ascertained (23).”
BackgroundTraber, M. G., & Bruno, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-66162-1.00007-x · Cited by 16
Farley, S. M., Leonard, S. W., Stevens, J. F., & Traber, M. G. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300659 · Cited by 12
“However, the documented adverse consequences of vitamin E in humans do not include death, but rather include increased bleeding [7], heart failure [8], and hemorrhagic stroke [9, 10].”
BackgroundVitamin Supplementation in the Elderly
Joshi, S. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.04.004 · Cited by 13
Oxidative Stress and Essential Hypertension
Rodrigo, R., Brito, R., & González, J. (2016) · InTech eBooks · doi:10.5772/64079 · Cited by 11
“Interestingly, some studies fail to demonstrate the beneficial effects of vitamin E in cardiovas‐ cular disease patients [66–69].”
ResultThe Roles of α‐Vitamin E and Its Analogues in Prostate Cancer
Ni, J., & Yeh, S. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(07)76019-3 · Cited by 12
Preventing Recurrent Stroke and Other Serious Vascular Events
Warlow, C. P., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Stroke · doi:10.1002/9780470696361.ch16 · Cited by 12
Adjunctive Vitamin E Treatment in Wilson Disease and Suggestions for Future Trials
Shen, L., & Ji, H. (2010) · Hepatology · doi:10.1002/hep.23665 · Cited by 12
Molecular Intricacies and the Role of ER Stress in Diabetes
Balasubramanyam, M., Singh, L. P., & Rangasamy, S. (2012) · Experimental Diabetes Research · doi:10.1155/2012/958169 · Cited by 14
Hydrogen peroxide formation by Nox4 limits malignant transformationPreprint
Helfinger, V., von Gall, F. F., Henke, N., Kunze, M. M., Schmid, T., Heidler, J., Wittig, I., Radeke, H. H., Marschall, V., Anderson, K. E., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/177055 · Cited by 12
“Nevertheless, the prospective randomized clinical trials on antioxidant supplementation have failed to provide protection and in some studies antioxidants even increased the risk of negative outcome (1, 2).”
BackgroundVitamin E and cardiovascular diseases: an interest to public health?
da Silva, A. G. C. L., Ribeiro, K. D. D. S., de Araújo, G. E. A., Oliveira, L. D. S., & Lyra, C. D. O. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000112 · Cited by 12
Scientific opinion on the tolerable upper intake level for vitamin E
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Knutsen, H. K., Maciuk, A., Mangelsdorf, I., McArdle, H. J., et al. (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8953 · Cited by 11
Moyad, M. A. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.174 · Cited by 11
Miranda, C. T. D. O. F., Duarte, V. H. R., Cruz, M. S., Duarte, M. K. R. N., de Araújo, J. N. G., dos Santos, A. M. Q. S., de Oliveira, J. M., Paiva, M. S. M. O., de Rezende, A. A., Hirata, M. H., et al. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/6104169 · Cited by 11
Diabetes mellitus and heart failure: an update on pathophysiology and therapy
Potere, N., BUONO, M. G. D., Vecchié, A., Porreca, E., ABBATE, A., DENTALI, F., & Bonaventura, A. (2022) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.22.05967-1 · Cited by 11
Vitamin E and conflicting understandings in noncommunicable diseases: Is it worth supplementing?
Trugilho, L., Alvarenga, L., Cardozo, L., Barboza, I., Leite, M., Fouque, D. P., & Mafra, D. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.12.147 · Cited by 11
Transition Metals and Other Forms of Oxidative Protein Damage in Renal Disease
Monnier, V. M., Nemet, I., Sell, D. R., & Weiss, M. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_2 · Cited by 11
Unterschemmann, K., Ehrmann, A., Herzig, I. D., Andreevski, A.-L., Lustig, K., Schmeck, C., Eitner, F., & Grundmann, M. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00373.2020 · Cited by 11
Banni, S., Montisci, R., Sanfilippo, R., Finco, G., Sanna, D., Giordano, E., Murru, E., Cordeddu, L., Carta, G., Banni, D., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-41 · Cited by 11
“Future studies on this direction may explain some apparent discrepancies on the lack of efficacy of antioxidant therapy in some disease where oxidative stress is involved [21,22].”
BackgroundPierini, R., Kroon, P. A., Guyot, S., Johnson, I. T., & Belshaw, N. J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.004 · Cited by 11
“As these protective effects do not appear to be directly attributable to conventional micronutrients [7], much attention has focussed on the putative antitumorigenic effects of polyphenols, which exhibit antioxidant properties [8] and the ability to modulate cell signalling pathways [9].”
BackgroundGersh, B. J. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70171-5 · Cited by 11
Drug–Nutrient Interactions in the Elderly
Sultan, S., Heis, Z., & Jahangir, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00007-8 · Cited by 11
Treatment- and disease-related complications of prostate cancer.
Simoneau, A. R. (2006) · Europe PMC (PubMed Central) · Cited by 11
Reproducibility in experimentation – the implications for regulatory toxicology
Berry, S. C. (2014) · Toxicology Research · doi:10.1039/c4tx00069b · Cited by 10
Lysosomal dysfunction in diabetic cardiomyopathy
Kobayashi, S., Hahn, Y., Silverstein, B., Singh, M., Fleitz, A., Van, J., Chen, H., & Liang, Q. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1113200 · Cited by 12
“However, clinical trials supplementing antioxidants have failed to provide a positive outcome in the management of cardiovascular diseases (Lonn et al., 2002; Sacco et al., 2003; Lonn et al., 2005; Sesso et al., 2012; Schwingshackl et al., 2017; Pickering et al., 2018).”
BackgroundWang, M. T. M., Gamble, G. D., Bolland, M. J., & Grey, A. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101533 · Cited by 10
New insights into how adenovirus might lead to obesity: An oxidative stress theory
Waye, M. M. Y. (2011) · Free Radical Research · doi:10.3109/10715762.2011.571684 · Cited by 10
Vitamin E supplementation: what's the harm in that?
Miller, E. R., & Güallar, E. (2009) · Clinical Trials · doi:10.1177/1740774509103248 · Cited by 10
“The Women’s Health Study [4], by far the largest of these trials, the Womens’ Antioxidant Cardiovascular Study (WACS) [5], and the HOPETOO [6] study, an extension of the HOPE trial, all showed nonsignificant albeit increased mortality among those randomized to vitamin E supplements (2–4% higher risk) (Table 1).”
ResultElemental Metabolomics: Modulation of Egg Metallome with Flavonoids, an Exploratory Study
Pappas, A. C., Zoidis, E., Goliomytis, M., Simitzis, P., Sotirakoglou, Κ., Charismiadou, M. A., Nikitas, C., Danezis, G., Deligeorgis, S. G., & Georgiou, C. A. (2019) · Antioxidants · doi:10.3390/antiox8090361 · Cited by 10
“It is well established that vitamin E and ascorbic acid are among the most effective antioxidants in biologic systems in preventing oxidative detrimental effects [49], despite some randomized controlled trials that revealed that vitamin E has no effect in cardiovascular or cancer prevention [50].”
BackgroundIs At Least One Vitamin Helping Our Vasculature?
Schulz, E., Steven, S., & Münzel, T. F. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04118 · Cited by 10
Mitochondrial Targeted Interventions for AgingPreprint
Liu, S. Z., Chiao, Y. A., Rabinovitch, P. S., & Marcinek, D. J. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041199 · Cited by 11
Latest innovations in the treatment of Wilson's disease
Zheng, Z., Dong, Y., & Wu, Z. (2022) · iLiver · doi:10.1016/j.iliver.2022.09.002 · Cited by 9
“However, the bene fi cial effects of vitamin E remain hotly debated, and many trials have failed to demonstrate that vitamin E can prevent cardiovascular disease or cancer [55].”
Ho, H., Gu, P., Wang, Y., Li, J., Chiu, D. T., Cheng, M., & Chen, C. (2008) · BioFactors · doi:10.1002/biof.5520340205 · Cited by 9
Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heart
van den Meiracker, A. H., & Batenburg, W. W. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328305e195 · Cited by 9
Zhao, Z., Ji, H., Zhao, Y., Liu, Z., Sun, R., Li, Y., & Ni, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1114221 · Cited by 9
Haslam, D. B. (2011) · Clinical Obesity · doi:10.1111/j.1758-8111.2011.00031.x · Cited by 9
An overview of permanent vascular access in hemodialyzed patients.
Checheriţă, I. A., Tuta, L. A., David, C., Peride, I., Niculae, A., GEAVLETE, B. F., Pricop, C., & Ion, D. A. (2015) · PubMed · Cited by 9
Ghorbanzadeh, V., Jafarpour, A., Pirnia, A., Pajouhi, N., Khaksarian, M., Veiskarami, S., & Nazari, A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1729816 · Cited by 10
Jabbour, J., Manana, B., Zahreddine, A., Al‐Shaar, L., Bazarbachi, A. A., Blaise, D., & Cheikh, J. E. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01154-0 · Cited by 9
Ojo, O. O., & Leake, D. S. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1964494 · Cited by 8
Alfonso, H. S., Fritschi, L., de Klerk, N. H., Ambrosini, G. L., Beilby, J. P., Olsen, N. J., & Musk, A. W. (2006) · European Journal of Cancer Prevention · doi:10.1097/00008469-200608000-00003 · Cited by 9
“In a recent, large intervention study, vitamin E supplementation was not associated with cancer in patients with diabetes or cardiovascular disease (Lonn et al., 2005).”
BackgroundDietary factors and risk of heart failure: A systematic review
Djoussé, L., Kochar, J., & Gaziano, J. M. (2007) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-007-0053-1 · Cited by 9
“However, the Heart Outcomes Prevention Evaluation (HOPE) study [ 42 ] reported 13% and 21% increased risk of HF and HF hospitalization, respectively.”
BackgroundDavis, M. B., & Duvernoy, C. S. (2011) · Women s Health · doi:10.2217/whe.11.34 · Cited by 9
Essential nutrient requirements of the elderly
Skully, R. (2014) · Nutrition and Dietary Supplements · doi:10.2147/nds.s35381 · Cited by 9
“While diets which are high in vitamin E are associated with lower mortality from coronary artery disease (CAD),(44) RCTs have not demonstrated that vitamin E supplements lower the risk of CAD.(45,46) Similarly, while dietary vitamin E consumption is associated with lower rates of cognitive decline,(47) high dose suppl…”
Rakel, D. P., & Rindfleisch, J. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50092-2 · Cited by 9
Combination of physical activity, nutrition, or other metabolic factors and vaccine response
Kenneth, W. H. (2007) · Frontiers in bioscience · doi:10.2741/2444 · Cited by 10
Insights into the Disappointing Clinical Trials of Antioxidants in Neurodegenerative Diseases
Shen, L., & Ji, H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1307 · Cited by 9
Primary prevention of age related macular degeneration
Evans, J. R. (2007) · BMJ · doi:10.1136/bmj.39351.478924.be · Cited by 9
Chen, Y., Zhu, J., Gui, H., Liu, M., Zhang, Y., Wu, Z., Liu, C., & Wang, M. (2026) · Antioxidants · doi:10.3390/antiox15070803 · Cited by 8
Need for a nutrition-specific scientific paradigm for research quality improvement
Flanagan, A., Bradfield, J., Kohlmeier, M., & Ray, S. (2023) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2023-000650 · Cited by 8
Antioxidant therapies for obstructive sleep apnea: A systematic review and meta-analysis
Boppana, T. K., Mittal, S., Madan, K., Tiwari, P., Mohan, A., & Hadda, V. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03050-z · Cited by 9
“The clinical trials of antioxidants for cardiovascular health have shown no benefit and may potentially be harmful [24].”
Demosthenous, M., Antoniades, C. A., Tousoulis, D., Margaritis, M., Marinou, K., & Stefanadis, C. (2011) · Artery Research · doi:10.1016/j.artres.2011.03.003 · Cited by 9
“Even though vitamin E has antioxidant properties, large studies discourage the use of vitamin E for the prevention of cardiovascular events.(132)”
BackgroundEffect of Vitamins and Dietary Supplements on Cardiovascular Health
Goudarzi, S., Montazerin, S. M., Najafi, H., Shojaei, F., & Chi, G. (2020) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000212 · Cited by 8
Xu, Y., Liu, S., Chen, J., & Wang, Y. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04558 · Cited by 8
Ni, C., Zhou, W., Yu, M., Li, X., Li, J., Cui, Y., & Cui, W. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300269 · Cited by 8
Förstermann, U. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00005-8 · Cited by 11
Lack of effect of α-tocopherol on in vitro angiogenesis
Navarra, T., Turco, S. D., Papa, A., Battaglia, D. B. R., Lazzerini, G., & Basta, G. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.04.003 · Cited by 8
Effect of diet on vascular health
McEvoy, C. T., Neville, C. E., Temple, N. J., & Woodside, J. V. (2013) · Reviews in Clinical Gerontology · doi:10.1017/s0959259813000191 · Cited by 8
Dietary intake of nuts and cardiovascular prognosis.
Good, D., Lavie, C. J., & Ventura, H. O. (2009) · PubMed Central · Cited by 8
Roberts, C. K. (2014) · CRC Press eBooks · doi:10.1201/b16783-5 · Cited by 8
High-Risk Nutrients in the Aging Population
Tucker, K. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_21 · Cited by 9
Metadata
- Authors
- The HOPE and HOPE-TOO Trial Investigators
- Affiliations
- Population Health Research Institute (CA)
- Corresponding author
- The HOPE and HOPE-TOO Trial Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-03-16
- Volume
- 293
- Issue
- 11
- Pages
- 1338
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1678920698
- Cited by
- 1,209
- References
- 20
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 31 · 2023: 35 · 2022: 35 · 2021: 34 · 2020: 45 · 2019: 37 · 2018: 22 · 2017: 44 · 2016: 48 · 2015: 56 · 2014: 95 · 2013: 70 · 2012: 87
- FWCI
- 58.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council Canada
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin E supplementation, long-term supplementation, cancer incidence, cancer mortality, cardiovascular events, myocardial infarction, stroke, cardiovascular mortality, heart failure, unstable angina, revascularization, older adults, vascular disease, diabetes mellitus
- MeSH terms
- Aged, Antioxidants, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Female, Humans, Male, Middle Aged, Neoplasms, Risk, Vascular Diseases, Dietary Supplements, alpha-Tocopherol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review